Physician profile
Louis Scotti
NPI 1134199151
$1,600.92
in general payments reported to CMS, 2019-2025
11 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $408 · 2023: $384 · 2024: $272 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $387.60 | 2022-2023 | Krystexxa |
| Abbott Laboratories | $212.47 | 2024 | Proclaim |
| Kerecis Limited | $190.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Advanced Oxygen Therapy INC. | $142.24 | 2021-2022 | |
| Smith+Nephew, INC. | $141.51 | 2023-2025 | Collagenase Santyl, Acticoat 4" X 4", Iodosorb Ointment 40g USA |
| Nevro Corp. | $125.42 | 2022-2023 | Senza |
| Amgen INC. | $124.79 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $124.58 | 2022 | |
| Medela LLC | $91.70 | 2021 | |
| Treace Medical Concepts, INC. | $44.38 | 2024 | |
| Mimedx Group, INC. | $15.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Scotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.